GlaxoSmithKline is a finished-dose manufacturer based in United States. It appears in 2,375 regulatory filings across 23 regulators, without an active US DMF or CEP on file. Its filings concentrate with MHRA (UK), Health Canada and SWISSMEDIC (CH). Its GMP standing is certified by TMDA (TZ), NAFDAC (NG) and MFDS (Korea), among 4 authorities.
| Site | FDA FEI |
|---|---|
| Mississauga, United Arab Emirates | Not on file |
| MISSISSAUGA, Canada | Not on file |
| Baar, Switzerland | Not on file |
| TIANJIN, China | Not on file |
| Cairo, Nigeria | Not on file |
| Nairobi, Tanzania | Not on file |
2 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| MHRA (UK) | 863 | 1 |
| Health Canada | 583 | None |
| SWISSMEDIC (CH) | 166 | None |
| DH (HK) | 126 | None |
| EMA | 119 | None |
| ANSM (FR) | 118 | None |
| TMDA (TZ) | None | 4 |
| NAFDAC (NG) | None | 3 |
| MFDS (Korea) | None | 2 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. GlaxoSmithKline comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.